Organon & Co. (OGN)
13.92
+0.02
(+0.14%)
USD |
NYSE |
Nov 18, 16:00
13.92
0.00 (0.00%)
After-Hours: 20:00
Organon Price to Book Value : 3.064 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 3.060 |
| November 16, 2026 | 3.060 |
| November 13, 2026 | 3.060 |
| November 12, 2026 | 3.060 |
| November 11, 2026 | 3.058 |
| November 10, 2026 | 3.058 |
| November 09, 2026 | 3.049 |
| November 06, 2026 | 3.053 |
| November 05, 2026 | 3.036 |
| November 04, 2026 | 3.044 |
| November 03, 2026 | 3.049 |
| November 02, 2026 | 3.042 |
| October 30, 2026 | 3.047 |
| October 29, 2026 | 3.040 |
| October 28, 2026 | 3.034 |
| October 27, 2026 | 3.027 |
| October 26, 2026 | 3.025 |
| October 23, 2026 | 3.027 |
| October 22, 2026 | 3.027 |
| October 21, 2026 | 3.027 |
| October 20, 2026 | 3.029 |
| October 19, 2026 | 3.027 |
| October 16, 2026 | 3.029 |
| October 15, 2026 | 3.029 |
| October 14, 2026 | 3.025 |
| Date | Value |
|---|---|
| October 13, 2026 | 3.031 |
| October 12, 2026 | 3.031 |
| October 09, 2026 | 3.040 |
| October 08, 2026 | 3.027 |
| October 07, 2026 | 3.036 |
| October 06, 2026 | 3.025 |
| October 05, 2026 | 3.016 |
| October 02, 2026 | 3.020 |
| October 01, 2026 | 3.018 |
| September 30, 2026 | 3.016 |
| September 29, 2026 | 3.587 |
| September 28, 2026 | 3.584 |
| September 25, 2026 | 3.584 |
| September 24, 2026 | 3.582 |
| September 23, 2026 | 3.584 |
| September 22, 2026 | 3.576 |
| September 21, 2026 | 3.571 |
| September 18, 2026 | 3.571 |
| September 17, 2026 | 3.574 |
| September 16, 2026 | 3.568 |
| September 15, 2026 | 3.566 |
| September 14, 2026 | 3.563 |
| September 11, 2026 | 3.561 |
| September 10, 2026 | 3.558 |
| September 09, 2026 | 3.568 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.698 |
| Pacira Biosciences, Inc. | 2.043 |
| ANI Pharmaceuticals, Inc. | 2.497 |
| Corcept Therapeutics, Inc. | 8.883 |
| Veru, Inc. | 1.388 |
Price to Book Value Related Metrics
| PE Ratio | 18.10 |
| PS Ratio | 0.6082 |
| Price to Free Cash Flow | 5.047 |
| Price | 13.92 |
| Earnings Yield | 5.52% |
| Market Cap | 3.656B |
| Operating PE Ratio | 3.101 |
| Normalized PE Ratio | 9.585 |